Firm News: Drugs & Devices: Page 12

Ellen Relkin, of counsel attorney for Weitz and Luxenberg’s team focusing on defective drugs and medical devices, has been filing lawsuits against the manufacturers of Invokana. Those manufacturers are Janssen Pharmaceuticals, and its affiliated companies Mitsubishi Tanabe Pharmaceuticals and Johnson & Johnson.  She spoke about the injuries this drug is causing, including diabetic ketoacidosis, with…

On November 18, 2015, U.S. District Judge Kathryn H. Vratil of Kansas appointed the first plaintiffs steering committee (PSC) in a federal multidistrict litigation (MDL) with a majority of women members. This is a significant and appropriate achievement given that women comprise a large segment of the lawyers in the United States and about 50…

Weitz & Luxenberg, P.C., is now accepting cases involving total hip arthroplasty patients who have been implanted with an OMNIlife science Apex K2 Modular Hip System hip implant. W&L began investigating these cases after reports of patient injuries appeared in medical journals. There was also a reported rate of revision in the Australian Orthopaedic Association…

Nationally known personal injury and mass tort law firm Weitz & Luxenberg, P.C., today announced that one of its lead attorneys, Paul J. Pennock, successfully argued to a federal court judicial panel to consolidate into a single multidistrict litigation dozens of lawsuits claiming injuries from use of power morcellators manufactured by Johnson & Johnson subsidiary…